Tired of working with agencies who don't challenge your thinking?

Agencies who deliver market access projects reactively and never commit to really understanding what you need?

Tired of writers who don't understand payers?

Or reviewing yet another document without a redthread of narrative?

So were we. And we did something about it.

Discover extraordinary deliverables that deliver

Put simply, people and their expertise are the difference between a good agency and a great one.

Our market access and value communications specialists understand your challenge in trying to achieve patient access to therapies in evolving healthcare systems. And we understand that you need to communicate a clear story – or redthread – that cuts through.

Explore why clients trust redthread to deliver

Clients love our signature blend of market access, writing, and story-finding expertise. That’s because we help you achieve your goals by combining brilliant writing with in-depth market access knowledge. Spend less time reviewing and briefing by working with our experts.

  • redthread worked with our team as a genuine partner who strived to achieve the best outcome for the company. The [NICE] submission was very complex but you wouldn't know this from the high-quality work that was delivered within extremely tight timelines. We also valued the flexibility and ease at which redthread adapted to the unexpected changes and access challenges that cropped up during the process.

    HTA submission
    Market Access Manager, Oncology, Top 20 pharma

  • The work was produced to a high standard and you added lots of value by providing suggestions that we hadn't thought of. You made the whole project very easy as little input was needed on our side.

    Cross-functional workshop for UK handover of early-stage asset
    Market Access Project Lead, Top 20 pharma

  • The team at redthread are completely trustworthy and I can always count on them to produce high-quality deliverables. They make projects friendly and fun. Even in the face of extremely tight deadlines, the team are calm and committed to deliver. The team are extremely flexible and organised - they were able to deliver and facilitate a fantastic cross-functional workshop with only 3 weeks’ notice.

    UK oncology access support, including HTA strategy and submission writing
    Market Access Lead, Oncology, Top 20 pharma

  • Excellent quality of work first and foremost. [The team are also] very pleasant to work with - always professional and flexible. [They] also contribute to the strategy and don't only execute the material development which we very much value.

    UK oncology access support, including HTA strategy and submission writing
    Director, EUCAN, Access and Reimbursement, Top 20 pharma

  • Right from our initial meeting you filled me with so much confidence due to your knowledge and expertise…the speed with which you picked up the therapy area was impressive… you were a real leader for us during this submission and worked tirelessly to ensure we remained on track.

    HTA submission
    Medical Lead, Oncology, Top 20 pharma

  • I know I can always rely on redthread to produce extremely high-quality deliverables.

    You are incredibly accommodating, proactive and reliable, and truly understand the importance of clearly articulating a value proposition within all types of deliverables.

    UK oncology access support, including HTA strategy and submission writing
    Manager, HTA Centre of Excellence

  • I really appreciated your firm but fair approach when dealing with some issues we experienced. Rather than just shy away, I felt you really stuck your neck out for our company in such a way that I felt you were actually part of our company!

    HTA submission
    Medical Lead, Oncology, Top 20 pharma

Latest Case Studies


Cross-company collaboration on a NICE HTA

Seamless collaboration with Delta Hat to deliver NICE & SMC submissions under tight timelines…

Read more from Cross-company collaboration on a NICE HTA

Early Dialogue

HTA scientific advice for a cell therapy in lymphoma

Supporting Global and UK pharma with early dialogue in the UK and France…

Read more from HTA scientific advice for a cell therapy in lymphoma